Back

DNA methylation effects on Van der Woude Syndrome phenotypic variability

Seaberg, A.; Awotoye, W.; Qian, F.; Dunlay, L.; Butali, A.; Murray, J. C.; Moreno-Uribe, L. M.; Petrin, A.

2023-12-06 genetic and genomic medicine
10.1101/2023.11.04.23298094 medRxiv
Show abstract

OBJECTIVEVan der Woude Syndrome (VWS) classically presents with combinations of lip pits (LP) and orofacial clefts, with marked phenotypic discordance even amongst individuals carrying the same mutation. Such discordance suggests a possible role for epigenetic factors as phenotypic modifiers. Both IRF6, causal for 70% of VWS cases, and TP63 interact in a regulatory loop to coordinate epithelial proliferation and differentiation for palatogenesis. We hypothesize that differential DNA methylation (DNAm) in CpG sites within regulatory regions of IRF6 and TP63 are associated with VWS phenotypic discordance. METHODSWe measured DNAm levels of CpG sites located in the promoter regions of IRF6 and TP63 and in an IRF6 enhancer element (MCS9.7) in 83 individuals with VWS grouped within 5 phenotypes for primary analysis: 1=CL+/-P+LP, 2=CL+/-P, 3=CP+LP, 4=CP, 5=LP and 2 phenotypes for secondary analysis: 1=any cleft and LP, 2= any cleft without LP. DNA samples were bisulfite converted and pyrosequenced with target-specific primers. Methylation levels were compared amongst phenotypes. RESULTSCpG sites in the IRF6 promoter showed statistically significant differences in methylation among phenotypic groups in both analyses (P<0.05). Individuals with any form of cleft (Groups 1-4) had significantly higher methylation levels than individuals with lip pits only (Group 5). In the secondary analysis, individuals in Group 1 (cleft+LP) had significantly higher methylation than Group 2 (cleft only). CONCLUSIONResults indicated that hypermethylation of the IRF6 promoter is associated with more severe phenotypes (any cleft +/- lip pits); thus, possibly impacting an already genetically weakened IRF6 protein and leading to a more severe phenotype.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
American Journal of Medical Genetics Part A
17 papers in training set
Top 0.1%
22.5%
2
Human Molecular Genetics
130 papers in training set
Top 0.1%
10.4%
3
PLOS ONE
4510 papers in training set
Top 23%
8.2%
4
Journal of Medical Genetics
28 papers in training set
Top 0.1%
6.4%
5
European Journal of Human Genetics
49 papers in training set
Top 0.2%
4.2%
50% of probability mass above
6
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.1%
4.0%
7
Scientific Reports
3102 papers in training set
Top 37%
3.6%
8
Genes
126 papers in training set
Top 0.4%
2.7%
9
Human Mutation
29 papers in training set
Top 0.2%
2.6%
10
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 3%
1.9%
11
Pediatric Pulmonology
14 papers in training set
Top 0.2%
1.7%
12
Genetics in Medicine
69 papers in training set
Top 0.6%
1.7%
13
Frontiers in Genetics
197 papers in training set
Top 5%
1.7%
14
Frontiers in Molecular Biosciences
100 papers in training set
Top 2%
1.7%
15
npj Genomic Medicine
33 papers in training set
Top 0.4%
1.7%
16
International Journal of Molecular Sciences
453 papers in training set
Top 9%
1.5%
17
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
1.2%
18
Gene Reports
13 papers in training set
Top 0.5%
0.9%
19
Cureus
67 papers in training set
Top 4%
0.9%
20
BMC Medical Genomics
36 papers in training set
Top 1%
0.8%
21
Muscle & Nerve
10 papers in training set
Top 0.3%
0.8%
22
Journal of Clinical Medicine
91 papers in training set
Top 6%
0.8%
23
Genomics
60 papers in training set
Top 2%
0.8%
24
Frontiers in Human Neuroscience
67 papers in training set
Top 3%
0.7%
25
Clinical Epigenetics
53 papers in training set
Top 1%
0.7%
26
Human Genomics
21 papers in training set
Top 0.5%
0.6%
27
Epigenetics
43 papers in training set
Top 1%
0.6%
28
Frontiers in Pediatrics
29 papers in training set
Top 1%
0.6%
29
BMC Genomic Data
12 papers in training set
Top 0.3%
0.6%